X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs ELDER PHARMA - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS ELDER PHARMA J.B.CHEMICALS/
ELDER PHARMA
 
P/E (TTM) x 17.6 -0.2 - View Chart
P/BV x 2.4 0.1 2,363.4% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 J.B.CHEMICALS   ELDER PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
ELDER PHARMA
Jun-14
J.B.CHEMICALS/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs318380 83.7%   
Low Rs200188 106.1%   
Sales per share (Unadj.) Rs148.0491.2 30.1%  
Earnings per share (Unadj.) Rs19.1-3.2 -599.8%  
Cash flow per share (Unadj.) Rs23.914.4 166.2%  
Dividends per share (Unadj.) Rs0.500-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs128.9376.5 34.2%  
Shares outstanding (eoy) m84.8220.54 413.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.70.6 302.5%   
Avg P/E ratio x13.6-89.3 -15.2%  
P/CF ratio (eoy) x10.819.7 54.8%  
Price / Book Value ratio x2.00.8 266.1%  
Dividend payout %2.60-   
Avg Mkt Cap Rs m21,9515,833 376.3%   
No. of employees `0002.7NA-   
Total wages/salary Rs m1,8412,179 84.5%   
Avg. sales/employee Rs Th4,590.9NM-  
Avg. wages/employee Rs Th673.4NM-  
Avg. net profit/employee Rs Th592.1NM-  
INCOME DATA
Net Sales Rs m12,55110,089 124.4%  
Other income Rs m542257 211.1%   
Total revenues Rs m13,09310,346 126.6%   
Gross profit Rs m2,055-792 -259.5%  
Depreciation Rs m412361 114.1%   
Interest Rs m962,756 3.5%   
Profit before tax Rs m2,088-3,653 -57.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m469125 374.8%   
Profit after tax Rs m1,619-65 -2,477.0%  
Gross profit margin %16.4-7.8 -208.6%  
Effective tax rate %22.5-3.4 -655.7%   
Net profit margin %12.9-0.6 -1,991.1%  
BALANCE SHEET DATA
Current assets Rs m7,7789,240 84.2%   
Current liabilities Rs m4,3589,998 43.6%   
Net working cap to sales %27.2-7.5 -362.8%  
Current ratio x1.80.9 193.1%  
Inventory Days Days5546 118.1%  
Debtors Days Days8060 133.5%  
Net fixed assets Rs m5,71310,124 56.4%   
Share capital Rs m170206 82.5%   
"Free" reserves Rs m10,5475,582 188.9%   
Net worth Rs m10,9377,734 141.4%   
Long term debt Rs m04,889 0.0%   
Total assets Rs m15,57422,882 68.1%  
Interest coverage x22.8-0.3 -7,015.3%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.80.4 182.8%   
Return on assets %11.011.8 93.6%  
Return on equity %14.8-0.8 -1,751.4%  
Return on capital %20.022.3 89.5%  
Exports to sales %48.73.0 1,603.2%   
Imports to sales %7.10.4 1,657.4%   
Exports (fob) Rs m6,115307 1,994.4%   
Imports (cif) Rs m88943 2,061.9%   
Fx inflow Rs m6,169307 2,012.1%   
Fx outflow Rs m1,285125 1,025.6%   
Net fx Rs m4,884181 2,693.8%   
CASH FLOW
From Operations Rs m1,39711,754 11.9%  
From Investments Rs m-320-561 57.1%  
From Financial Activity Rs m-1,196-6,762 17.7%  
Net Cashflow Rs m-1024,432 -2.3%  

Share Holding

Indian Promoters % 55.4 39.6 139.9%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 7.5 45.2%  
FIIs % 3.9 16.8 23.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 36.1 102.5%  
Shareholders   30,437 16,479 184.7%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   GLENMARK PHARMA  UNICHEM LAB  DR. REDDYS LAB  BIOCON LTD  ALEMBIC LTD  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 284 Points Up; FMCG & Metal Stocks Top Gainers(Closing)

Indian share markets settled higher today taking cues from their Asian peers. At the closing bell, BSE Sensex ended up by 284 points.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Banks are Raising FD Rates and That's Good News(Vivek Kaul's Diary)

Aug 7, 2018

Lending to the retail segment remains strong, whereas lending to the service sector has picked up dramatically.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Aug 17, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 8-QTR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS